Literature DB >> 3565517

Branhamella catarrhalis keratitis.

D G Heidemann, E Alfonso, R K Forster, S Ullman, S P Holland, A Mendelsohn, D Miller.   

Abstract

Branhamella catarrhalis, formerly known as Neisseria catarrhalis, has structural similarities to Neisseria gonorrhoeae, but is generally considered to be nonpathogenic. We studied the clinical and laboratory data of four previously reported cases and six additional cases of B. catarrhalis keratitis. All patients had a predisposing ocular or systemic condition, or both. There were various clinical characteristics, but in most cases the infiltrate occurred in the central or paracentral cornea. A prompt response to treatment with a cephalosporin and aminoglycoside antibiotic was noted in all cases. Two patients had corneal perforations, which probably resulted from a delay in treatment. Gram-negative diplococci from corneal scrapings may not necessarily represent N. gonorrhoeae.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3565517     DOI: 10.1016/s0002-9394(14)74282-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Twelve-year analysis of microbial keratitis trends at a UK tertiary hospital.

Authors:  S Z Tan; A Walkden; L Au; C Fullwood; A Hamilton; A Qamruddin; M Armstrong; A K Brahma; F Carley
Journal:  Eye (Lond)       Date:  2017-04-28       Impact factor: 3.775

Review 2.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

3.  Selective medium for Branhamella catarrhalis with acetazolamide as a specific inhibitor of Neisseria spp.

Authors:  M Vaneechoutte; G Verschraegen; G Claeys; A M van den Abeele
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

4.  Seven-Year Analysis of Microbial Keratitis Tendency at an Ophthalmology Department in Poland: A Single-Center Study.

Authors:  Klaudia Ulfik; Sławomir Teper; Michał Dembski; Anna Nowińska; Ewa Wróblewska-Czajka; Edward Wylęgała
Journal:  J Ophthalmol       Date:  2020-10-28       Impact factor: 1.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.